C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas

被引:30
作者
Kallio, R [1 ]
Bloigu, A
Surcel, HM
Syrjälä, H
机构
[1] Oulu Univ Hosp, Dept Radiotherapy & Oncol, Oulu 90220, Finland
[2] Natl Publ Hlth Inst, KTL, Dept Oulu, Oulu 90101, Finland
[3] Oulu Univ Hosp, Dept Infect Control, Oulu 90220, Finland
关键词
malignancy; infections; neoplastic fever; C-reactive protein; erythrocyte sedimentation rate;
D O I
10.1007/s005200000181
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The goals of our work were to study prospectively the possibility of differentiating between infections and neoplastic fever in adult cancer patients on admission, by means of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) or of follow-up CRP values. Patients and methods were as follows: the final infection group consisted of 56 patients and the noninfection group of 10 patients with neoplastic fever; CRP was measured on days 0, 3 and 5 and ESR at entry. The main results showed that the median CRP did not differ between the groups (91 mg/l vs 102 mg/l) on entry, while the ESR level was higher in the neoplastic fever group (50 mm/H vs 89 mm/H, P=0.023). On admission, both markers had low area under receiver operating characteristic curves for the demonstration of infection (CRP 0.42; ESR 0.27). The CRP level dropped significantly in the infection group within 5 days (P=0.009). We conclude that neither of the markers was useful in differentiating between infections and neoplastic fever on admission, but that the follow-up CRP values were advantageous in this respect.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 45 条
[1]  
BALLOU SP, 1992, ADV INTERNAL MED, V37, P313
[2]  
BOGGS DR, 1960, CANCER-AM CANCER SOC, V13, P1240, DOI 10.1002/1097-0142(196011/12)13:6<1240::AID-CNCR2820130613>3.0.CO
[3]  
2-9
[4]  
Brigden M, 1998, Postgrad Med, V103, P257
[5]  
Brigden ML, 1999, AM FAM PHYSICIAN, V60, P1443
[6]   SIGNIFICANCE OF FEVER IN NEOPLASTIC DISEASE [J].
BROWDER, AA ;
PETERSDORF, RG ;
HUFF, JW .
ANNALS OF INTERNAL MEDICINE, 1961, 55 (06) :932-+
[7]   UTILITY OF NAPROXEN IN THE DIFFERENTIAL-DIAGNOSIS OF FEVER OF UNDETERMINED ORIGIN IN PATIENTS WITH CANCER [J].
CHANG, JC ;
GROSS, HM .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (04) :597-603
[8]   NEOPLASTIC FEVER RESPONDS TO THE TREATMENT OF AN ADEQUATE DOSE OF NAPROXEN [J].
CHANG, JC ;
GROSS, HM .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (04) :552-558
[9]  
CHILD JA, 1980, CANCER-AM CANCER SOC, V45, P318, DOI 10.1002/1097-0142(19800115)45:2<318::AID-CNCR2820450220>3.0.CO
[10]  
2-C